Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Curaleaf Holdings Inc (OP:CURLF)

1.650 +0.227 (+15.95%)
Streaming Delayed Price Updated: 3:59 PM EDT, Aug 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Curaleaf Holdings Inc

< Previous 1 2 3 4 5 6 7 8 9
...
50 51 Next >
Cannabis Stock Gainers And Losers From March 20, 2025
 
Via Benzinga
Topics Cannabis
Cannabis Stock Movers For March 17, 2025
 
Via Benzinga
Topics Cannabis
Bearish Sentiment Across The Cannabis Space - Check Full Movers For March 13, 2025
 
Via Benzinga
Topics Cannabis
Grön Launches New Edibles Flavors Across Curaleaf Dispensaries In Arizona
 
Via Benzinga
Bullish Sentiment Across The Cannabis Space - Check Full Movers For March 11, 2025
 
Via Benzinga
Topics Cannabis
Stocks Drop As Trade War Escalates: What's Driving Markets Tuesday?
U.S. stocks plunged Tuesday as President Donald Trump‘s tariffs on key trade partners came into effect, prompting retaliatory measures and intensifying global trade tensions. 
Via Benzinga
Topics World Trade
Curaleaf's Q4 Profit Swing Ignites Retail Chatter, But Shrinking Revenue Dampens The High
Chairman and CEO Boris Jordan pointed to the company's strengthened cash position, with $107 million in cash at year-end, and operating and free cash flow of $163 million and $70 million. 
Via Stocktwits
Tesla Rebounds While Tariffs Weigh On Manufacturing: What's Driving Markets Monday?
Stocks fell broadly on Monday to start the month of March with all three major indices red in midday trading. Investors digested a decline in February's ISM Manufacturing PMI data which fell to 50.3%,... 
Via Benzinga
This Week In Cannabis: Big Earnings Reports, Ice Cube's New Brand, Trump's Mixed Signals, Germany's Import Boom And Much More
This week in cannabis news: major acquisitions, regulatory battles, earnings rallies and Ice Cube's new brand launch. 
Via Benzinga
Topics Cannabis Government
Germany's Cannabis Imports Increase 4x In 2024 Amid Regulatory Changes: Which Countries Are Top Providers?
Germany's medical cannabis imports surged 4X in Q4 2024, driven by new laws. Canada & Portugal lead supply. 
Via Benzinga
Topics Cannabis
This Marijuana Stock Just Shocked Its Investors With a Huge Piece of Good News
Via The Motley Fool
Topics Cannabis
Cannabis Stock Valuations Reflect No Expectation Of Federal Reform: Study
Viridian Capital's latest report shows cannabis stocks pricing in no rescheduling or 280E relief, leaving MSOs stuck in valuation limbo. 
Via Benzinga
Topics Cannabis
Cannabis Stock Movers For January 9, 2025
 
Via Benzinga
Topics Cannabis
Amplify To Liquidate Cannabis-Focused MJUS ETF As Regulatory Uncertainty Weighs On Sector
Amplify ETFs plans to liquidate MJUS, a cannabis-related ETF, due to regulatory issues. Other cannabis ETFs also struggling with DEA's indecisiveness. 
Via Benzinga
Topics Cannabis ETFs
DEA Accused Of Bias In Cannabis Rescheduling Hearings: Weed Stocks Plummeted In 2024 As Process Drags On
DEA judge orders agency to respond to allegations of opposing marijuana rescheduling and improper communication with opponents. Cannabis stocks declined in 2024 due to concerns about DEA review. 
Via Benzinga
Topics Cannabis
Surgeon General's Alcohol Cancer Warning And Dry January: This Cannabis Company Has You Covered
Just in time for Dry January, Curaleaf announced an expansion to the company's fast-acting Select Zero Proof Hemp THC Seltzers. 
Via Benzinga
Topics Cannabis
The Price Is Right: This Weed Real Estate Stock Proves Conservative Strategies Bring Returns
New Lake Capital Partners (OTC:NLCP), a real estate company focused on cannabis properties, offers an attractive investment with a 9.1% dividend yield, well above the return on 10-year government... 
Via Benzinga
Topics Cannabis
EXCLUSIVE: Drug Expert Dr. Carl Hart Slams Cannabis Prohibition Amid Hemp-THC Surge
Dr. Carl Hart discusses hemp THC, unregulated markets, and the need for federal cannabis legalization to reduce risks and protect consumers. 
Via Benzinga
Topics Cannabis
Why Cannabis Sales Are Down In Massachusetts And New Mexico: The Numbers Behind The Dip
Massachusetts' average revenue per dispensary dropped to $362k/month, down 8% year-over-year, in New Mexico sales went down 3% in November. 
Via Benzinga
Topics Cannabis
Europe Says Thanks But We'll Do It Ourselves - Canada Leads In Raw Cannabis Exports, Not Oil
While dried flower exports have flourished, the growth of Canada's cannabis extracts, including oils and vapes, has been more erratic. 
Via Benzinga
Topics Cannabis
Illinois Cannabis Sales Back On Track In October Hitting $142.3M After Slight September Dip
ollowing a drop in September cannabis sales numbers in Illinois, October figures totaled $142.3 million, a 4.2% increase sequentially, reported New Cannabis Ventures' Alan Brochstein. Cannabis sales... 
Via Benzinga
Topics Cannabis
Ho-Ho-Holy Smokes! Record Weed Sales Drive Dispensaries To Stock Smart This Holiday Season
Flower remained the top-selling form factor, accounting for 43% of total sales, followed by vape at 28%, and edibles. 
Via Benzinga
Curaleaf Holdings: Is This Cannabis Company A Buy Or Hold?
In this article, we analyze Curaleaf using technical indicators, focusing on key levels and potential mid-term strategies. Let's dive in. 
Via Benzinga
Topics Cannabis
Is MariMed A Safe Haven In The Wake Of Florida's Cannabis Legalization Defeat?
For investors, MariMed represents a fundamentally strong outlier, but industry-wide challenges remain a drag on stock performance. 
Via Benzinga
Topics Cannabis
Diversify Around And Find Out: Can Vegas Superstore And Florida Sales Boost This Weed Penny Stock?
Is this 40-cent cannabis stock undervalued? Zuanic & Associates dives into its growth potential and market prospects. 
Via Benzinga
Topics Cannabis
Cannabis Cuts Opioid Prescriptions By 53%, Utah Study Suggests
Discover how cannabis for pain management reduced opioid prescriptions by 53% in Utah, signaling new opportunities for medical markets. 
Via Benzinga
Topics Cannabis
Cannabis Stock Gainers And Losers From November 29, 2024
 
Via Benzinga
Topics Cannabis
Pharma-Grade Cannabis Could Hit Walgreens & CVS—But Can The Industry Survive The FDA?
As the formal review process for rescheduling cannabis unfolds, industry players are closely watching its potential to transform the sector. 
Via Benzinga
Topics Cannabis
Flora Growth Taps Europe's CBD Boom With $500K Czech-Slovak Partnership Renewal
 
Via Benzinga
Federal Policy Could Add $3 Billion To Cannabis Industry: On Track To Reach $55 Billion By 2030
According to LeafLink, over the next 2-3 years, 5,000 non-MSO retailers are projected to open in key states, increasing store counts by 70%. 
Via Benzinga
Topics Cannabis
< Previous 1 2 3 4 5 6 7 8 9
...
50 51 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.